The Alliance for Aging Research and the AFib Optimal Treatment Task Force have released a new survey that found that atrial fibrillation patients are active in the decision-making process regarding their treatment. Learn more and access the survey reports at: Alliance for Aging Research Releases Survey of AFib Patients 65+ that Finds Active Participation in …
Read More
Action for Stroke Prevention, an alliance of renowned health experts and patient organizations, has published new reports calling for policy makers and the medical and patient communities to join forces to prevent atrial fibrillation-related strokes. Learn more at: New Report Confirms Europe is on the Brink of a Stroke Crisis
Read More
Just ahead of World Stroke Day (October 29), policy makers have joined over 90 medical and patient organizations, including StopAfib.org, and more than 100,000 people, in calling for prevention of atrial fibrillation-related strokes to be a National Healthcare Priority. To learn more, and view the press releases for Europe, Latin America, and the Asia Pacific …
Read More
The Atrial Fibrillation Optimal Treatment Task Force, led by the Alliance for Aging Research, has just released a consensus statement developed by a group of leading afib stroke prevention experts. We at StopAfib.org are proud to have been part of the development of this consensus statement, which recommends a process for assessing afib stroke and …
Read More
Although the total number of stroke deaths declined by more than 50 percent between 1978 and 2006, racial disparities in stroke deaths have remained and efforts to eliminate health disparities have been unsuccessful. Between ages 45 and 65, blacks are 2 to 3 times more likely to die from stroke than whites, but we haven’t …
Read More
Our January EP Lab Digest Patient Perspective column, Stuck in the Middle: Afib Patients on Rate Control, focuses on how rate control treatment (such as beta blockers) alone impacts the quality of life of those living with atrial fibrillation. The column also explores things doctors and patients may wish to consider in determining an appropriate …
Read More
As a patient, you probably see lots of hype-filled reports about various drugs. After a drug is approved, there’s an inevitable blitz of negative publicity which often scares people away from important new solutions that could help them. There has been so much news lately about Multaq (dronedarone), the drug designed to provide the benefits …
Read More
In this video, Dr. Patrick Ellinor, electrophysiologist at Massachusetts General Hospital, discusses research into genetic links to atrial fibrillation. The CHARGE AF or AFGen Consortium, which he co-leads, has identified three regions of genetic susceptibility for atrial fibrillation. The researchers have found that individuals with an immediate family member with afib have a significantly increased …
Read More
In this video, Dr. Keith Ferdinand, Chief Science Officer of the Association of Black Cardiologists, talked about heart disease and atrial fibrillation among minorities, especially blacks and African Americans. He talked about why blacks appear to have less afib than whites, and what blacks should be doing to prevent AF and heart disease. Watch the …
Read More
Up to 30% of patients could have very late recurrence of atrial fibrillation after catheter ablation, according to research highlighted at the recent Boston AF Symposium. Very late recurrence, which is when atrial fibrillation resumes more than one year after ablation, may be the result of age, gender, type of afib, and existence of other …
Read More